Company Filing History:
Years Active: 2016-2021
Title: **Innovations of Thomas McCann, Jr. in Diabetes Management**
Introduction
Thomas McCann, Jr., an accomplished inventor based in Pottstown, PA, has made significant contributions to the field of diabetes management with five patented inventions. His innovative approaches have the potential to transform how diabetes is managed, providing improved solutions for those affected by the condition.
Latest Patents
Among McCann's latest patents are two groundbreaking systems designed for diabetes management:
1. **Diabetes Management System with Automatic Basal and Manual Bolus Insulin Control** - This patent presents a system that includes a delivery device, glucose sensor, and a controller. The delivery device administers insulin while the glucose sensor measures the subject's glucose levels. The system utilizes a model predictive control algorithm to calculate basal insulin doses based on physiological data, allowing for manual bolus doses initiated by the subject. This innovation ensures precise insulin delivery tailored to individual needs.
2. **Method and System for a Hybrid Control-to-Target and Control-to-Range Model Predictive Control of an Artificial Pancreas** - This patent describes a sophisticated management system for diabetes incorporating an infusion pump, glucose sensor, and a controller. The controller enables a switch between different modes of model predictive control based on predetermined blood glucose values, allowing for enhanced customization and efficacy in insulin delivery.
Career Highlights
Throughout his career, Thomas McCann, Jr. has worked with reputable companies that specialize in medical technology. Notably, he has been associated with Animas Corporation and Lifescan IP Holdings, LLC, where he has played a pivotal role in developing cutting-edge diabetes management solutions.
Collaborations
McCann's journey in innovation has been enriched through collaborations with esteemed professionals in his field, including Daniel Finan and Ramakrishna Venugopalan. These partnerships have undoubtedly contributed to the success and advancement of his patented inventions.
Conclusion
Thomas McCann, Jr.'s innovative contributions to diabetes management through his patents reflect his commitment to improving the lives of those living with this condition. By developing advanced systems that integrate technology and physiological data, McCann continues to drive progress in the medical field, underscoring the importance of innovation in healthcare.